Relaxation Therapy (instrumentation) < Release < Reliability

Facettes :

List of bibliographic references indexed by Release

Number of relevant bibliographic references: 12.

Ident.	Authors (with country if any)	Title
001498 (2011)	Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni]	PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
001724 (2011)	Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Ann Hsu [États-Unis] ; Martin J. O'Connell [États-Unis] ; Nishit B. Modi [États-Unis] ; Hsuan-Ming Yao [États-Unis] ; Sherron H. Kell [États-Unis] ; Suneel K. Gupta [États-Unis]	Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
001A67 (2010)	Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]	Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
001B38 (2010)	Ray L. Watts [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Kapil Sethi [États-Unis] ; Matthew Stern [États-Unis] ; Robert A. Hauser [États-Unis] ; Warren Olanow [États-Unis] ; Alex M. Gray [États-Unis] ; Bryan Adams [États-Unis] ; Nancy L. Earl [États-Unis]	Onset of dyskinesia with adjunct ropinirole prolonged‐release or additional levodopa in early Parkinson's disease
001D19 (2010)	Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]	Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
001D25 (2010)	Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis]	Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations
002453 (2009)	Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis]	An open‐label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease
002A60 (2008)	Peter Valkovic [Slovaquie] ; Hana Brozova [République tchèque] ; Kai Bötzel [Allemagne] ; Evzen Ruzicka [République tchèque] ; Jan Benetin [Slovaquie]	Push and Release Test Predicts Better Parkinson Fallers and Nonfallers than the Pull Test : Comparison in OFF and ON Medication States
003031 (2007)	Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; Manel Barbanoj [Espagne] ; Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Carmen García-Sánchez [Espagne]	Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study
003300 (2006)	Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]	Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies
003653 (2006)	William Bara-Jimenez [États-Unis] ; Tzvetelina D. Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Murat Aksu [États-Unis] ; Thomas N. Chase [États-Unis]	Glutamate release inhibition ineffective in levodopa-induced motor complications
004136 (2003)	Ruediger Hilker [Allemagne] ; Juergen Voges [Allemagne] ; Mehran Ghaemi [Allemagne] ; Ralf Lehrke [Allemagne] ; Jobst Rudolf [Allemagne] ; Athanasios Koulousakis [Allemagne] ; Karl Herholz [Allemagne] ; Klaus Wienhard [Allemagne] ; Volker Sturm [Allemagne] ; Wolf-Dieter Heiss [Allemagne]	Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Release" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Release" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Release
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024